Current Management and Unmet Needs in Alopecia Areata: Viewpoint From a Malaysian Perspective - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Management Strategies and Existing Gaps in Alopecia Areata: Insights from Malaysia

  • By

  • Azura Mohd Affandi

  • Adawiyah Jamil

  • Noor Zalmy Azizan

  • Felix Boon-Bin Yap

  • Kin Fon Leong

  • Agnes Yoke Hui Heng

  • Siti Nuraihan

  • Wooi Chiang Tan

  • Latha Selvarajah

  • Teeba Raja

  • Evelyn Wen Yee Yap

  • Peter Wee Beng Ch'ng

  • Tze Yuen Teoh

  • Mei Ying Tey

  • September 21, 2026

Share

Objective:

To bring together existing knowledge regarding alopecia areata (AA) epidemiology, clinical burden, and management practices in Malaysia, while identifying principal unmet needs, including the need for improved data collection and clinical guidelines.

Approach:
  • Epidemiological Overview: Alopecia areata affects approximately 1 in 1000 individuals, with a lifetime risk of about 2%. It is more common in children (1.92%) than adults (1.47%).
  • Comorbidities: AA is associated with various comorbidities including vitiligo, lupus, psoriasis, and psychiatric disorders, with increased anxiety rates among affected individuals.
  • Management Practices: Initial management in Malaysia often involves topical corticosteroids, with referrals to dermatology for uncertain diagnoses or inadequate treatment responses.
  • Healthcare System Insights: Patients may seek care in primary settings or directly consult private dermatologists, but there are significant gaps in epidemiological data and clinical guidelines.
Key Findings:
  • AA has a substantial psychological impact, leading to anxiety and depression.
  • There is a lack of comprehensive evaluation of disease burden and clinical guidelines in Malaysia.
  • Ethnic distribution of AA patients in Malaysia shows a relatively balanced representation, with Malays being the most frequent.
Interpretation:

The findings highlight the need for improved data collection and tailored clinical guidelines for managing alopecia areata in Malaysia.

Limitations:
  • Substantial deficiencies in epidemiological information regarding AA in Malaysia.
  • Limited studies on the clinical burden and management practices specific to the Malaysian context.
Conclusion:

Addressing the gaps in knowledge and management practices, including improved data collection and tailored clinical guidelines, is essential for improving care for patients with alopecia areata in Malaysia.

Sources:

Original Source(s)

Related Content